Global Infrared Spectroscopy for Pharmaceutical Market Growth 2026-2032
Description
The global Infrared Spectroscopy for Pharmaceutical market size is predicted to grow from US$ 509 million in 2025 to US$ 805 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.
Infrared spectroscopy for pharmaceutical refers to IR spectrometers (most commonly mid-IR FTIR and near-IR/NIR instruments) used to obtain molecular “vibrational fingerprints” of drug substances, excipients, intermediates, and drug products for identification and certain quantitative/quality attributes.
The upstream supply chain includes optical and electronic subsystems (IR/NIR sources, interferometer/monochromator, detectors), sampling interfaces (e.g., transmission cells, diffuse reflectance accessories, ATR crystals), and software/algorithms (especially chemometrics for NIR models and libraries).
Downstream users include pharmaceutical manufacturers, CDMOs, QC/QA laboratories, and official control labs, where IR is deployed across off-line, at-line, on-line, and in-line modes depending on whether testing is performed in the lab, near the line, or directly connected to the process. Regulatory guidance specifically frames NIR procedures for evaluating attributes such as identity, strength, quality, purity, and potency, and describes how measurement mode and interfaces are documented in filings/controls.
In 2025, global sales of infrared spectroscopy for pharmaceutical reached approximately 7,649 units, with an average global market price of around US$ 68 K/unit. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 40% to 60%.
Pharmaceutical demand for infrared spectroscopy (FTIR/NIR) is moving from “laboratory confirmation” toward “manufacturing process control.” Under GMP operations, infrared methods are valued for speed, non-destructive testing, and minimal sample preparation, making them well suited for incoming material identification, formulation or solid-state consistency checks, and rapid release of key quality attributes such as assay-related metrics and moisture—helping shorten wait times while maintaining compliance.
As PAT and quality-by-design thinking become more widely embedded in regulatory practice, manufacturers increasingly combine NIR/FTIR with in-line sampling, probes, and chemometric models to continuously monitor unit operations such as blending, granulation, drying, and coating—shifting from “after-the-fact testing” to “real-time monitoring plus feedback control.” This elevates the importance of compliant software, model lifecycle governance, model transfer across instruments, and validation services in purchasing decisions.
On the supply side, differentiation is no longer only about hardware specifications, but about an integrated “instrument + model + compliant delivery” capability: robust optical platforms, traceable calibration and reference frameworks, strong spectral libraries and chemometric toolchains, and service/documentation packages that support validation, controlled change, and data integrity expectations. For new entrants, practical entry points often lie in application-specific probes or accessories, compliant software and systems integration, and localized validation and maintenance capacity.
LP Information, Inc. (LPI) ' newest research report, the “Infrared Spectroscopy for Pharmaceutical Industry Forecast” looks at past sales and reviews total world Infrared Spectroscopy for Pharmaceutical sales in 2025, providing a comprehensive analysis by region and market sector of projected Infrared Spectroscopy for Pharmaceutical sales for 2026 through 2032. With Infrared Spectroscopy for Pharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infrared Spectroscopy for Pharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global Infrared Spectroscopy for Pharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infrared Spectroscopy for Pharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infrared Spectroscopy for Pharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infrared Spectroscopy for Pharmaceutical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infrared Spectroscopy for Pharmaceutical.
This report presents a comprehensive overview, market shares, and growth opportunities of Infrared Spectroscopy for Pharmaceutical market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
FTIR Spectrometer
Dispersive IR Spectrometer
Other
Segmentation by Spectral Region:
Near-Infrared (NIR)
Mid-Infrared (MIR)
Far-Infrared (FIR)
Segmentation by Deployment Mode:
Process Type
Benchtop Type
Handheld Type
Segmentation by Application:
Chemical Pharmaceuticals pharmaceutical
Biopharmaceuticals
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Shimadzu
Bruker
Revvity
Agilent Technologies
ABB
JASCO
FOSS
Metrohm
Process Insights
HORIBA
Avantes
Zeiss Spectroscopy
Focused Photonics
Shanghai Lengguang Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Infrared Spectroscopy for Pharmaceutical market?
What factors are driving Infrared Spectroscopy for Pharmaceutical market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infrared Spectroscopy for Pharmaceutical market opportunities vary by end market size?
How does Infrared Spectroscopy for Pharmaceutical break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Infrared spectroscopy for pharmaceutical refers to IR spectrometers (most commonly mid-IR FTIR and near-IR/NIR instruments) used to obtain molecular “vibrational fingerprints” of drug substances, excipients, intermediates, and drug products for identification and certain quantitative/quality attributes.
The upstream supply chain includes optical and electronic subsystems (IR/NIR sources, interferometer/monochromator, detectors), sampling interfaces (e.g., transmission cells, diffuse reflectance accessories, ATR crystals), and software/algorithms (especially chemometrics for NIR models and libraries).
Downstream users include pharmaceutical manufacturers, CDMOs, QC/QA laboratories, and official control labs, where IR is deployed across off-line, at-line, on-line, and in-line modes depending on whether testing is performed in the lab, near the line, or directly connected to the process. Regulatory guidance specifically frames NIR procedures for evaluating attributes such as identity, strength, quality, purity, and potency, and describes how measurement mode and interfaces are documented in filings/controls.
In 2025, global sales of infrared spectroscopy for pharmaceutical reached approximately 7,649 units, with an average global market price of around US$ 68 K/unit. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 40% to 60%.
Pharmaceutical demand for infrared spectroscopy (FTIR/NIR) is moving from “laboratory confirmation” toward “manufacturing process control.” Under GMP operations, infrared methods are valued for speed, non-destructive testing, and minimal sample preparation, making them well suited for incoming material identification, formulation or solid-state consistency checks, and rapid release of key quality attributes such as assay-related metrics and moisture—helping shorten wait times while maintaining compliance.
As PAT and quality-by-design thinking become more widely embedded in regulatory practice, manufacturers increasingly combine NIR/FTIR with in-line sampling, probes, and chemometric models to continuously monitor unit operations such as blending, granulation, drying, and coating—shifting from “after-the-fact testing” to “real-time monitoring plus feedback control.” This elevates the importance of compliant software, model lifecycle governance, model transfer across instruments, and validation services in purchasing decisions.
On the supply side, differentiation is no longer only about hardware specifications, but about an integrated “instrument + model + compliant delivery” capability: robust optical platforms, traceable calibration and reference frameworks, strong spectral libraries and chemometric toolchains, and service/documentation packages that support validation, controlled change, and data integrity expectations. For new entrants, practical entry points often lie in application-specific probes or accessories, compliant software and systems integration, and localized validation and maintenance capacity.
LP Information, Inc. (LPI) ' newest research report, the “Infrared Spectroscopy for Pharmaceutical Industry Forecast” looks at past sales and reviews total world Infrared Spectroscopy for Pharmaceutical sales in 2025, providing a comprehensive analysis by region and market sector of projected Infrared Spectroscopy for Pharmaceutical sales for 2026 through 2032. With Infrared Spectroscopy for Pharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infrared Spectroscopy for Pharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global Infrared Spectroscopy for Pharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infrared Spectroscopy for Pharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infrared Spectroscopy for Pharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infrared Spectroscopy for Pharmaceutical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infrared Spectroscopy for Pharmaceutical.
This report presents a comprehensive overview, market shares, and growth opportunities of Infrared Spectroscopy for Pharmaceutical market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
FTIR Spectrometer
Dispersive IR Spectrometer
Other
Segmentation by Spectral Region:
Near-Infrared (NIR)
Mid-Infrared (MIR)
Far-Infrared (FIR)
Segmentation by Deployment Mode:
Process Type
Benchtop Type
Handheld Type
Segmentation by Application:
Chemical Pharmaceuticals pharmaceutical
Biopharmaceuticals
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Shimadzu
Bruker
Revvity
Agilent Technologies
ABB
JASCO
FOSS
Metrohm
Process Insights
HORIBA
Avantes
Zeiss Spectroscopy
Focused Photonics
Shanghai Lengguang Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Infrared Spectroscopy for Pharmaceutical market?
What factors are driving Infrared Spectroscopy for Pharmaceutical market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infrared Spectroscopy for Pharmaceutical market opportunities vary by end market size?
How does Infrared Spectroscopy for Pharmaceutical break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
123 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Infrared Spectroscopy for Pharmaceutical by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Infrared Spectroscopy for Pharmaceutical by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
